Hinge Health authorizes $250M share repurchase; Q3 free cash flow $118M

Hinge Health, Inc.

Board approved up to $250M repurchase of Class A common stock on Nov 10, 2025.
Q3 2025 cash from operations $108M, free cash flow $118M; cash and investments ~$500M.
Repurchases may be made in open market or private transactions; no minimum obligation.
Company expects to fund repurchases with existing cash and cash from operations.
Buyback may be modified, suspended, or terminated at any time at board's discretion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.